LAX.SH
SHARDA CROPCHEM LTD.·PESTICIDES 28.50·Fertilizers & Agrochemicals Companies
Price
659.6
-2.55%52W Range
Market Cap
₹5,950.94 Cr
Traded: ₹7.08 Cr (0.12%) 0.0x
Free Float: ₹766.48 Cr (0.92% of FF traded)
Volume · 60D trend
1.07 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Return | +8.0% | +19.0% | +22.0% | -29.0% | -- | Stable |
| Profit | +14.0% | +24.0% | +26.0% | -- | +49.0% | Accelerating |
| Sales | +16.0% | +17.0% | +9.0% | -- | +19.0% | Stable |
| ROE | +16.0% | +15.0% | +13.0% | -- | -- | Decelerating |
Quarterly Results
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,074 | 2,065 | 1,289 | 929 | 985 | 1,829 | 929 | 777 | 785 | 1,312 | 632 | 581 | 638 | 1,482 | 1,017 |
| Expenses | 888 | 1,578 | 1,048 | 796 | 770 | 1,525 | 815 | 687 | 708 | 1,057 | 563 | 560 | 697 | 1,164 | 810 |
| Operating Profit | 186 | 487 | 241 | 133 | 215 | 303 | 115 | 90 | 77 | 255 | 69 | 21 | -59 | 318 | 207 |
| Other Income | 35 | 22 | 21 | 29 | 32 | 25 | 1 | 25 | 19 | -2 | 12 | 24 | 26 | 7 | 3 |
| Interest | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 5 | 1 | 2 | 1 |
| Depreciation | 100 | 87 | 83 | 76 | 78 | 72 | 69 | 69 | 65 | 54 | 69 | 74 | 70 | 68 | 65 |
| Profit Before Tax | 118 | 422 | 179 | 86 | 169 | 256 | 46 | 46 | 31 | 198 | 12 | -34 | -105 | 255 | 143 |
| Tax % | 26.0% | 24.0% | 19.0% | 13.0% | 16.0% | 20.0% | 32.0% | 7.0% | 11.0% | 28.0% | 62.0% | -18.0% | -15.0% | 22.0% | 24.0% |
| Net Profit | 88 | 319 | 145 | 74 | 143 | 204 | 31 | 42 | 27 | 143 | 5 | -28 | -89 | 199 | 108 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 9.8 | 35.3 | 16.1 | 8.2 | 15.8 | 22.6 | 3.5 | 4.7 | 3.0 | 15.9 | 0.5 | -3.1 | -9.8 | 22.0 | 12.0 |
| Sales Growth (YoY) | 9.0% | 12.9% | 38.8% | 19.6% | 25.5% | 39.4% | 47.0% | 33.7% | 23.0% | -11.5% | -37.9% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -48.0% | 60.2% | 38.8% | -5.7% | -46.1% | 96.9% | 19.6% | -1.0% | -40.2% | 107.6% | 8.8% | -8.9% | -57.0% | 45.7% | -- |
| OP Growth (YoY) | -13.5% | 60.7% | 109.6% | 47.8% | 179.2% | 18.8% | 66.7% | 328.6% | 230.5% | -19.8% | -66.7% | -- | -- | -- | -- |
| OP Growth (QoQ) | -61.8% | 102.1% | 81.2% | -38.1% | -29.0% | 163.5% | 27.8% | 16.9% | -69.8% | 269.6% | 228.6% | 135.6% | -118.6% | 53.6% | -- |
| Profit Growth (YoY) | -38.0% | 57.0% | 366.0% | 75.0% | 424.0% | 42.0% | 571.0% | 254.0% | 131.0% | -28.0% | -96.0% | -328.0% | -492.0% | 12.0% | 6.0% |
| EPS Growth (YoY) | -38.3% | 56.6% | 366.4% | 75.3% | 424.2% | 41.9% | 576.5% | 253.6% | 130.8% | -27.9% | -95.8% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -72.4% | 119.5% | 95.3% | -48.0% | -29.8% | 553.9% | -26.6% | 55.6% | -81.0% | 3017.7% | 116.7% | 68.8% | -144.6% | 83.5% | -- |
| OP Margin | 17.3% | 23.6% | 18.7% | 14.3% | 21.8% | 16.6% | 12.4% | 11.6% | 9.8% | 19.4% | 10.9% | 3.6% | -9.3% | 21.5% | 20.4% |
| Net Margin | 8.2% | 15.4% | 11.3% | 8.0% | 14.5% | 11.2% | 3.3% | 5.4% | 3.4% | 10.9% | 0.8% | -4.8% | -13.9% | 13.4% | 10.6% |
| Material Cost % | -- | 63.0% | 65.0% | 65.0% | 65.0% | 70.0% | 67.0% | 72.0% | 71.0% | 65.0% | 74.0% | 75.0% | 91.0% | 68.0% | 70.0% |
| Employee Cost % | -- | 1.0% | 1.0% | 1.0% | 2.0% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% | 2.0% | 1.0% | 1.0% | 1.0% |
| P/S | 1.11 | 1.50 | 2.06 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 9.50 | 11.62 | 18.33 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.90 | 2.52 | 3.88 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026
This is to inform that the trading window will be closed from 1st October, 2026 till 48 hours after the un-audited financial results are approved by the Board of Directors. The date of ....
Intimation of Schedule of Analyst / Institutional Investor Meeting
Voting Results for 23rd Annual General Meeting of the Company
Outcome of the 23rd Annual General Meeting of the Company
Newspaper Advertisement in relation to transfer of dividend and equity shares of the company to IEPF Authority.
To consider and approve Unaudited Financial Results for quarter ended 30th June, 2026
The Company has scheduled a Conference call for analyst and investors on Thursday, 30th July, 2026 at 03.30 P.M. IST.
Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve Unaudited Standalone & Consolidated ....
Newspaper Advertisement - 23rd Annual General Meeting of the Company
Annual Report for the financial year 2025-26.
Business Responsibility and Sustainability Reporting (BRSR) for the Financial Year 2025-26.
Notice of the 23rd Annual General Meeting of the Company to be held on Friday, 14th August, 2026 at 01:00 PM IST.
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026.
Intimation of Annual General Meeting and Book Closure date.
Intimation of Book closure and Record date to determine eligible members entitle to receive final dividend for the financial year 2025-26.
We hereby inform that the 23rd Annual General Meeting of the Company will be held on Friday, 14th August, 2026 at 01:00 pm IST through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
This is to inform that the trading window will be closed from 1st July, 2026 till 48 hours after the un-audited financial results are approved by the Board of Directors. The Date of Board ....
Earnings Call Transcript of the conference call held on 14th May 2026.
Intimation of Schedule of Analyst / Institutional Investor Meeting
Annual Secretarial Compliance Report for the financial year ended 31st March 2026.
Audio Recording of Earnings Call Q4 FY 2025-26.
The Board of Directors considered and recommended final dividend at the rate of Rs. 9.00 per share.
Newspaper Publication of Results for the quarter and year ended 31st March 2026
Audited Consolidated and Audited Standalone Financial Result for Financial Year ended 31st March 2026.
The Board of Directors considered and recommended final dividend at the rate of Rs. 9.00 per share
Media Release on Audited Financial Results for the quarter and financial year ended March 31, 2026.
Investor / Analyst Presentation for the Quarter and Year ended 31st March 2026.
Outcome of Board Meeting to consider and approve Audited Consolidated and Audited Standalone Financial Result for quarter and financial year ended 31st March 2026
The Company has scheduled conference call for analysist / Investor on Thursday i.e. 14th May, 2026 at 1.00 pm IST.
Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve This is to inform that Board ....
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026
This is to inform that the trading window will be closed from 1st April, 2026 till 48 hours after the audited financials results (Standalone and Consolidated) of the Company for the quarter ....
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
Crisil Ratings has reaffirmed its ''Crisil A1+'' rating on the short-term bank facilities of Sharda Cropchem Limited (SCL).
Earnings Call Transcript of the conference call held on 30th January, 2026
The Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2025 have been approved and taken on record by the Board of Directors in ....
Audio Recording of Earnings Call Q3 FY 2025-26.
The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter & nine months ended 31st December, 2025 pursuant ....
In continuation of our letter of today''s date on the Consolidated and Standalone Unaudited Financial Results for the quarter and nine months ended 31st December, 2025, we attach a copy ....
Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we are enclosing herewith the presentation to be made to ....
The Company has fixed Friday, 06th February, 2026 as the "RECORD DATE" for the purpose of ascertaining the eligibility of the shareholders for payment of Interim Dividend for the Financial ....
The Board of Directors considered, approved and took on record the Unaudited Financials Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2025. The ....
The Company has scheduled a Conference call for analyst and investors on Friday, 30th January, 2026 at 1.00 P.M. IST.
Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 ,inter alia, to consider and approve The meeting of Board of Directors ....
Certificate issued under Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018.
This is to inform that the trading window will be closed from 1st January, 2026 till 48 hours after the un-audited financial results are approved by the Board of Directors. The Date of ....
Transcript for conference call for Q2 FY 2025-26 financial results of the Company.
Intimation of Schedule of Analyst / Institutional Investor Meeting
Annual Reports
12Credit Ratings
6Concalls
41Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Jul 2025
31 Jul 2025May 2025
31 May 2025Jan 2025
31 Jan 2025Oct 2024
31 Oct 2024Jul 2024
31 Jul 2024May 2024
31 May 2024Jan 2024
31 Jan 2024Oct 2023
31 Oct 2023Jul 2023
31 Jul 2023May 2023
31 May 2023Jan 2023
31 Jan 2023Oct 2022
31 Oct 2022Jul 2022
31 Jul 2022May 2022
31 May 2022Jan 2022
31 Jan 2022Oct 2021
31 Oct 2021Jul 2021
31 Jul 2021May 2021
31 May 2021Jan 2021
31 Jan 2021Oct 2020
31 Oct 2020Aug 2020
31 Aug 2020Jun 2020
30 Jun 2020Jan 2020
31 Jan 2020Oct 2019
31 Oct 2019Jul 2019
31 Jul 2019May 2019
31 May 2019Jan 2019
31 Jan 2019Oct 2018
31 Oct 2018Jul 2018
31 Jul 2018May 2018
31 May 2018Jan 2018
31 Jan 2018Oct 2017
31 Oct 2017Jul 2017
31 Jul 2017May 2017
31 May 2017Jan 2017
31 Jan 2017Nov 2016
30 Nov 2016Aug 2016
31 Aug 2016May 2016
31 May 2016Jan 2016
31 Jan 2016Held by ETFs
1 ETFs hold shardacrop · sorted by weight
Held by Mutual Funds
7 schemes hold shardacrop · sorted by weight